Jiangxi Synergy Pharmaceutical (300636.SZ): Vildagliptin tablets obtain drug registration certificate.

14/01/2025

GMT Eight

Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company recently received the Drug Registration Certificate for Vildagliptin Tablets issued by the National Medical Products Administration (NMPA). Vildagliptin Tablets are used for the treatment of type 2 diabetes.

On January 13th, HSBC Holdings (00005) spent 54.84 million pounds to buy back 690.85 million shares.

On January 13th, STANCHART (02888) spent 5.31 million to repurchase 52,450 shares.

Contact: contact@gmteight.com

Jiangxi Synergy Pharmaceutical (300636.SZ): Vildagliptin tablets obtain drug registration certificate.

RECOMMEND

Ife Elevators (002774.SZ) controlling shareholder and its concerted action holder collectively reduced their holdings by 1% of the shares.

Some shareholders of Beijing Advanced Digital Technology (300541.SZ) have completed the reduction of 4.0141 million shares.

Baota Industry (000595.SZ) won the bid for a Chinese railway material procurement project of 28.96 million yuan.